<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201608223320N13</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2016-11-03</date_registration>
      <primary_sponsor>Nutrition Research Center, Tabriz University of Medical Scienses</primary_sponsor>
      <public_title>Effect of vitamin D on obesity</public_title>
      <acronym></acronym>
      <scientific_title>Effects of vitamin D supplementation on sirtuin-1, Angiogenesis factors  and  Matrix metalloproteinases enzmes in Obese subjects with Vitamin D Insufficiency/ Deficiency</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-10-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>44</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/3409</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>obesity.</hc_freetext>
      <i_freetext>Intervention 1: Intervention groups: receive 50000 IU vit D  as   blues along with low calorie diet for 12 weeks. Intervention 2: Control group: receive placebo of vitamin D (edible paraffin) with low calorie diet for 12 weeks.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Soodabeh Aliashrafi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nutrition and food science, Attarneyshabouri street, Golgasht street.</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 41 3335 7581</telephone>
        <email>SA.NUT89@yahoo.com</email>
        <affiliation>Faculty of Nutrition and food science, Tabriz University of Medical Scienses</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Mehrangiz Ebrahimi Mamagani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Nutrition and food science, Attarneyshabouri street, Golgasht street</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 413335229500</telephone>
        <email>ebrahimimamagani@tbzmed.ac.ir</email>
        <affiliation>Faculty of Nutrition and food science, Tabriz University of Medical Scienses</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: age of 18-60; BMI= 30-40 Kg/m2; Serum Vitamin D &lt; 50 nmol/L  and interesting in participation in research.&#13;
Exclusion criteria: Alcohol consumption; smoking; pregnant; lactating; menopausal women;  very active subjectes or athletes; diet 3 mounts before research ; Glucose and lipid lowering Drugs ; antihypertensive medication;  consumption vit D supplementation and multivitamin mineral during research; use of medication affecting Vitamin D metabolism;  subjects suffering from metabolic disease ;cardiovascular diseases;renal diseases ; nephrolithiasis; &#13;
  liver diseases; thyroid disease; autoimmune disease; cancer.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E66.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Obesity due to excess calories</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention groups: receive 50000 IU vit D  as   blues along with low calorie diet for 12 weeks</i_keyword>
      <i_keyword>Control group: receive placebo of vitamin D (edible paraffin) with low calorie diet for 12 weeks.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Inflammatory  factors (MCP-1, IL-1 beta). Timepoint: Beginning and end of the intervention. Method of measurement: ELISA Kit.</prim_outcome>
      <prim_outcome>Serum Angiogenesis factors. Timepoint: Beginning and end of the intervention. Method of measurement: ELISA Kit.</prim_outcome>
      <prim_outcome>Matrix metalloproteinases (MMP-2, MMP-9). Timepoint: Beginning and end of the intervention. Method of measurement: ELISA Kit.</prim_outcome>
      <prim_outcome>Sirtuin-1 (Sirt-1). Timepoint: Beginning and end of the intervention. Method of measurement: ELISA Kit.</prim_outcome>
      <prim_outcome>Toll like receptor-4 (TLR-4). Timepoint: Beginning and end of the intervention. Method of measurement: ELISA Kit.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Serum level of Vitamin D, calcium, Phosphorus and PTH hormon. Timepoint: Begining and end of intervention. Method of measurement: Vitamin D and PTH by using ELISA,  calcium and  Phosphorus by using  spectrophotometry.</sec_outcome>
      <sec_outcome>Fasting Blood Sugar (F.B.S.). Timepoint: Begining and end of intervention. Method of measurement: Enzymatic method.</sec_outcome>
      <sec_outcome>Lipid profile  (TC,LDL-c, HDL-c, TG). Timepoint: Begining and end of intervention. Method of measurement: Triglyceride, total cholesterol and HDL-cholesterol with enzymatic colorometric and LDL-cholesterol with Friedewald equation.</sec_outcome>
      <sec_outcome>Serum insulin level and  Insulin resistance. Timepoint: Begining and end of intervention. Method of measurement: insulin by using Elisa  and Insulin resistance by Calculation of HOMA-IR.</sec_outcome>
      <sec_outcome>Anthropometric measurements. Timepoint: Begining and end of intervention. Method of measurement: Weight and Height by using Seca scale and stadiometer respectively,  waist to hip ratio will be calculated  waist circumference divided to hip circumferenceas, Body mass index (BMI) will be calculated as weight in kilograms divided by the square of height in meters, fat mass and visceral fat mass by using body Analyser.</sec_outcome>
      <sec_outcome>Energy , macro and micro  nutrients intake. Timepoint: Baseline, 6 weeks  and  end of the  intervention. Method of measurement: 3 day Dietary record questionnair.</sec_outcome>
      <sec_outcome>Physical activity level. Timepoint: Baseline, 6 weeks  and  end of the  intervention. Method of measurement: International physical activity questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Nutrition Research Center, Tabriz University of Medical Scienses</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-10-16</approval_date>
        <contact_name>The Research Ethics Committee of Tabriz University of Medical Sciences</contact_name>
        <contact_address>Faculty of Nutrition and food science, Attarneyshabouri street, Golgasht street. Tabriz  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
